Background Treatment for autoimmune diseases such as systemic lupus erythematosus (SLE),
idiopathic inflammatory myositis, and systemic sclerosis often involves long-term immune …

Background Mobile health apps (MHA) have the potential to improve health care. The
commercial MHA market is rapidly growing, but the content and quality of available MHA are …

Idiopathic inflammatory myopathies are a group of rare, immune-mediated diseases that
primarily affect the skeletal muscle but can also involve other organs such as the lungs, skin, …

Background: Chronic rheumatic diseases need long-term treatment and professional supervision.
Mobile apps promise to improve the lives of patients and physicians. In routine practice…

Background: Mobile health (mHealth) defines the support and practice of health care using
mobile devices and promises to improve the current treatment situation of patients with …

Background Remote care and telehealth have the potential to expand healthcare access,
and the COVID-19 pandemic has called for alternative solutions to conventional face-to-face …

Antisynthetase syndrome (ASSD) is a rare clinical condition that is characterized by the
occurrence of a classic clinical triad, encompassing myositis, arthritis, and interstitial lung …

Objective To analyse the impact of the COVID-19 pandemic on rheumatic patients’ and
rheumatologists’ usage, preferences and perception of digital health applications (DHAs). …

Background Interstitial lung disease (ILD) is the most common cause of death in systemic
sclerosis. To date, the progression of systemic sclerosis-associated ILD is judged by the …

The coronavirus disease-2019 (COVID-19) pandemic continues to be a cause of unprecedented
global morbidity and mortality. Whilst COVID-19 vaccination has emerged as the only …